Subcutaneous administration of tocilizumab is effective in myointimal hyperplasia remodelling in refractory Takayasu arteritis

Subcutaneous administration of tocilizumab is effective in myointimal hyperplasia remodelling in refractory Takayasu arteritis

Takayasu arteritis (TA) is a chronic inflammatory disease of unknown origin that involves large and mediumsized arteries, primarily the aorta and its major branches. TA is a therapeutic challenge because corticosteroids and conventional immunosuppressive agents are not always effective or safe. Inte...

Full description

Bibliographic Details
Main Authors: A. Lo Gullo, G. Mandraffino, C.O. Aragona, A. Molica Colella, A. Saitta, E. Imbalzano
Format: Article
Language:English
Published: PAGEPress Publications 2017-12-01
Series:Reumatismo
Subjects:
Tocilizumab
intima media thickness
arterial stiffness
Takayasu arteritis
ultrasound.
Online Access:http://reumatismo.org/index.php/reuma/article/view/1013

Internet

http://reumatismo.org/index.php/reuma/article/view/1013

Similar Items